Iradimed earnings were $20.7M for the trailing 12 months ending Jun 30, 2025, with 10.1% growth year over year. The latest IRMD earnings report on Jun 30, 2025 announced Q2 2025 earnings of $5.8M, up 23.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IRMD reported annual earnings of $19.2M, with 11.9% growth.
IRMD past earnings growth
How has IRMD's earnings growth performed historically?
On IRMD's earnings call on Invalid Date, Iradimed (NASDAQ: IRMD) reported Q2 2025 earnings per share (EPS) of $0.45, up 15.38% year over year. Total IRMD earnings for the quarter were $5.77 million. In the same quarter last year, Iradimed's earnings per share (EPS) was $0.39.
As of the last Iradimed earnings report, Iradimed is currently profitable. Iradimed's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $20.66 million, a 10.8% increase year over year.
What was IRMD's earnings growth in the past year?
As of Iradimed's earnings date in Invalid Date, Iradimed's earnings has grown 10.14% year over year. This is 74.88 percentage points lower than the US Medical Devices industry earnings growth rate of 85.02%. IRMD earnings in the past year totalled $20.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.